Inventor
Baudouin GÉRARD
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds10%
C07KPeptides10%
Y02PClimate change mitigation technologies in the production or processing of goods10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
PatentTitleYear
12,043,626Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds202412,037,346Amino-substituted heteroaryls for treating cancers with EGFR mutations202411,981,687Methods of preparing cytotoxic benzodiazepine derivatives202411,926,619Certain pladienolide compounds and methods of use202411,760,759Process for preparing substituted indolines202311,420,982Methods of preparing cytotoxic benzodiazepine derivatives202211,390,633Methods of preparing cytotoxic benzodiazepine derivatives2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to IMMUNOGEN INC (4)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to NUVALENT INC (2)· patent assignee history
2024Patents assigned to EISAI R&D MAN CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 4 | 2022–2024 |
| NUVALENT INC | 2 | 2024 |
| EISAI R&D MAN CO LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2024 |